The minimal inhibitory concentrations (MIC) of apramycin, a unique aminocyclitol antibiotic, for 100 Escherichia coli isolates recovered from clinical cases of avian colibacillosis were determined using the agar dilution method. All isolates were inhibited at apramycin concentration of 8.0 micrograms/ml; 90 and 50% of the isolates were inhibited at 6.6 and 3.4 micrograms/ml, respectively. A commercial injectable product containing 200 mg apramycin/ml was administered intramuscularly (i.m.) to groups of 6- and 12-week-old turkeys at 10, 15 and 20 mg/kg. Apramycin was quickly absorbed from the i.m. injection site. Mean peak serum drug concentrations were reached 1 h after treatment and were 19.5, 27.5 and 36.0 micrograms/ml, respectively. The serum elimination half-life (t 1/2) of the drug ranged between 1.75 h for the 10 mg/kg dose and 2.5 h for the 20 mg/kg dose. Very low concentrations of the drug were found 24 h after treatment. Duration of serum apramycin concentrations in relation to the MIC, dose, and age of birds was determined.
[1]
S. Soback,et al.
Clinical pharmacology of apramycin in calves.
,
1985,
Journal of veterinary pharmacology and therapeutics.
[2]
J. Walton.
Apramycin, a new aminocyclitol antibiotic. I. In vitro microbiological studies.
,
1978,
The Journal of antimicrobial chemotherapy.
[3]
B. .. Moore,et al.
The in vitro activity of apramycin, a new aminocyclitol antibiotic.
,
1977,
The Journal of antimicrobial chemotherapy.